Federal contract award

75N91018F00001

SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NCI
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle75N91018D00012
Set-asideNot reported
Pricing typeCOST SHARING
Obligations$36.2M
Current contract value$39.8M
Potential contract value / ceiling$46.0M
Start dateMay 1, 2018
Current end dateApr 30, 2027
Potential end dateApr 30, 2028
Latest award activitySep 4, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 20 of 20 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 4, 2026P00019$137.6KSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Apr 27, 2026P00018$3.1MSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Sep 15, 2025P00017$-924.2KSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Jun 10, 2025P00016$0SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
May 1, 2025P00015$3.8MSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Apr 30, 2025P00014$27.2KSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Sep 26, 2024P00013$983.2KSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Apr 25, 2024P00012$3.7MSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Mar 20, 2024P00011$38.5KSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Apr 19, 2023P00010$4.1MSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Mar 9, 2023P00009$202.5KSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Apr 26, 2022P00008$4.0MSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Mar 1, 2022P00007$577.5KSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM.
Apr 21, 2021P00006$3.7MMOD. P00006 EXERCISES OPTION PERIOD 3 AND OBLIGATES INCREMENT 1 OF FUNDING.
Mar 29, 2021P00005$347.3KMOD. P00005 OBLIGATES INCREMENT 2 OF FUNDING FOR OPTION PERIOD 2.
Nov 10, 2020P00004$0MOD. P00004 CORRECTS HUMAN SUBJECT CODES DATA FIELDS IN THE NIH BUSINESS SYSTEM.
Apr 15, 2020P00003$4.2M(1.) MODIFICATION TO FUND OPTION YEAR 1, INCREMENT #2; (2.) EXERCISE OPTION YEAR 2; AND FUND OPTION YEAR 2, INCREMENT #1.
Apr 30, 2019P00002$4.1MSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
Feb 26, 2019P00001$323.9KSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
May 1, 20180$3.9MSURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM

Estimated positioning window

Apr 30, 2027 – Oct 30, 2027

Recompete signal:
75/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 75/100. Available recorded signals: 70 points.

Contract end 2028-04-30 (546 days from calculation)
+25 points
240 historical awards in this buyer and category group
+15 points
20 recorded award transactions
+10 points
Latest award action: 2026-09-04
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Verify whether remaining options may extend performance beyond the current end date.
  3. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  4. Review the award scope and buyer evidence before making a bid/no-bid decision.